Aesthetic Injectables Market - By Type (Botulinum Toxin, Dermal Fillers (Product (Hyaluronic Acid, Calcium Hydroxyapatite), Application (Face Lift, Wrinkle Reduction))), Gender, Age Group, End-user & Forecast2024

Description

Global Aesthetic Injectables Market size will grow at 10.2% CAGR from 2024 to 2032, due to the ongoing advancements in injectable technologies coupled with the growing awareness of available treatments. Rising innovations are offering safer and more effective solutions for addressing various cosmetic concerns, from wrinkles to facial volume loss. The versatility of injectable treatments for catering to a wide range of aesthetic needs is helping attract a broader consumer base. With consumers becoming more informed about the benefits and possibilities, the market will expand significantly. For instance, in February 2024, Merz Aesthetics introduced a new use for RADIESSE as an aesthetic injectable designed to enhance moderate to severe wrinkles in the decollete region.

The aesthetic injectables industry is classified on the basis of type, gender, age group, end-user, and region.

In terms of type, the market value from the dermal fillers segment will secure a 10.7% CAGR between 2024 and 2032, attributed to the surge in the demand for non-invasive cosmetic procedures. The strong desire for youthful appearance and the growing aging population is driving advancements in injectable technologies. Face lift injectables have grown popular as they offer a convenient alternative to traditional surgery, appealing to those seeking rejuvenation without the downtime. With an increasing number of individuals opting for these procedures worldwide, the segment will witness sustained growth.

Based on the end-user, the hospital segment in the aesthetic injectables industry will achieve a considerable foothold by 2032. This is propelled by the growing demand for minimally invasive cosmetic procedures performed in hospital settings, where patients benefit from advanced medical facilities and expert care. Additionally, the strong emphasis of hospitals on safety protocols and sterile environments aligns with the increasing emphasis on patient safety and satisfaction. As more individuals seek treatments like Botox and dermal fillers, hospitals will become the primary providers, further driving the product demand.

Asia Pacific aesthetic injectables market size will exhibit a 12.2% CAGR from 2024 to 2032, fueled by several factors, including the increasing disposable incomes in China and India, where aesthetic procedures are becoming more popular. The rising awareness of beauty and skincare coupled with technological advancements and the growing aging population are fueling the demand for injectable treatments. Overall, the presence of dynamic market landscape and demographic trends in Asia Pacific will prove favorable for the industry growth.

Product Code: 8040

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 Data collection
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing elderly population
  - 3.2.1.2 Rising awareness and focus about facial aesthetics in developed countries
  - 3.2.1.3 Increasing demand for minimally invasive cosmetic procedures
  - 3.2.1.4 Increasing number of professionals and facilities in developed countries
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with aesthetic injectables
  - 3.2.2.2 Side effects associated with these procedures
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Botulinum toxin
- 5.2.1 Botulinum toxin A
- 5.2.2 Botulinum toxin B
5.3 Dermal fillers
- 5.3.1 By product type
  - 5.3.1.1 Hyaluronic acid
  - 5.3.1.2 Calcium hydroxyapatite
  - 5.3.1.3 Poly-L-lactic acid
  - 5.3.1.4 Polymethyl-methacrylate microspheres (PMMA)
  - 5.3.1.5 Collagen
  - 5.3.1.6 Fat fillers
  - 5.3.1.7 Other dermal fillers
- 5.3.2 By application
  - 5.3.2.1 Face lift
  - 5.3.2.2 Facial correction
  - 5.3.2.3 Wrinkles reduction
  - 5.3.2.4 Acne scar
  - 5.3.2.5 Lipoatrophy
  - 5.3.2.6 Lip enhancement
  - 5.3.2.7 Hip augmentation
  - 5.3.2.8 Breast enhancement
  - 5.3.2.9 Hand rejuvenation
  - 5.3.2.10 Penis enlargement
  - 5.3.2.11 Blepharoplasty
  - 5.3.2.12 Neck & chin lift
  - 5.3.2.13 Other applications

Chapter 6 Market Estimates and Forecast, By Gender, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Female
6.3 Male

Chapter 7 Market Estimates and Forecast, By Age Group, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 15 - 30
7.3 31 - 40
7.4 41 - 50
7.5 51 - 60
7.6 > 60

Chapter 8 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Dermatology clinics
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 AbbVie Inc (Allergan Plc.)
10.2 Bio-Med Private Limited
10.3 Bioxis Pharmaceuticals
10.4 Cytophil, Inc.
10.5 Galderma S.A.
10.6 Ipsen SA
10.7 Laboratories Vivacy SAS
10.8 Merz Pharma GmbH & Co. KGaA.
10.9 Mesoestetic
10.10 Sinclair Pharma (Huadong Medicine Co., Ltd)
10.11 Suneva Medical, Inc
10.12 Teoxane Laboratories

Aesthetic Injectables Market - By Type (Botulinum Toxin, Dermal Fillers (Product (Hyaluronic Acid, Calcium Hydroxyapatite), Application (Face Lift, Wrinkle Reduction))), Gender, Age Group, End-user & Forecast2024 - 2032